Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to attend LEAP 2026 on September 2. (IMAGE)

InSilico Medicine

Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to attend LEAP 2026 on September 2.

Caption

He will deliver a presentation at the "Deep Dive: Rewriting Healthcare with Predictive Intelligence" forum at 15:10, followed by a panel discussion titled "Beyond the Horizon: Breakthroughs at the Edge of Market Entry" at 18:05.

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.